/Gregory Downey/ - 07 May 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Financial Officer
Signature
/Gregory Downey/
Issuer symbol
LEXX
Transactions as of
07 May 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 12:32:08 UTC
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 1,833 07 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Other $0 -8,000 -32% $0.000000 17,000 07 May 2021 Common Shares 8,000 $9.60 Direct F1
holding LEXX Stock Options 8,000 07 May 2021 Common Shares 8,000 $9.60 Direct
holding LEXX Stock Options 12,000 07 May 2021 Common Shares 4,000 $5.04 Direct
holding LEXX Stock Options 16,000 07 May 2021 Common Shares 4,000 $5.04 Direct
holding LEXX Stock Options 20,000 07 May 2021 Common Shares 4,000 $5.04 Direct
holding LEXX Stock Options 25,000 07 May 2021 Common Shares 5,000 $5.31 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cancelled Options